Visual detection of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis strains by use of an asymmetrically split peroxidase DNAzyme

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3443-3450

  Deng, Minggang ^b,d   Feng, Shuo ^a   Luo, Fengling ^b   Wang, Shaoru ^a   Sun, Xiaoming ^b   Zhou, Xiang ^a,c   Zhang, Xiao Lian ^b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

^d HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DNA PEROXIDASE; PEROXIDASE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CODON; DNA PROBE; DNA SEQUENCE; DNA STRUCTURE; GENE IDENTIFICATION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RPOB GENE; WILD TYPE;

BACTERIAL PROTEINS; DNA, CATALYTIC; DRUG RESISTANCE, BACTERIAL; HUMANS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; PEROXIDASE; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84867543602     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01292-12     Document Type: Article

References (32)

1. Aw LD, Neo JL, Uttamchandani M. 2010. Visual detection of DNA from Salmonella and Mycobacterium using split DNAzymes. Mol. Biosyst. 6:792-794.
2. Caugant DA, Sandven P, Eng Jeque JJT, Tønjum T. 1995. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microbiol. Drug Resist. 4:3212-3261.
3. Deng MG, Zhang D, Zhou YY, Zhou X. 2008. Highly effective colorimetric and visual detection of nucleic acids using an asymmetrically split peroxidase DNAzyme. J. Am. Chem. Soc. 130:13095-13102.
4. De Viedma DG. 2003. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecular approaches. Clin. Microbiol. Infect. 9:349-359.
5. Donnabella V, et al. 1994. Isolation of the gene for the beta subunit of RNA polymerase from rifampin-resistant Mycobacterium tuberculosis and identification of new mutations. Am. J. Respir. Cell Mol. Biol. 11:639-643.
6. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement: global burden of tuberculosis, estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686.
7. Grimes J, Gerasimova YV, Kolpashchikov DM. 2010. Real-time SNP analysis in secondary-structure-folded nucleic acids. Angew. Chem. Int. Ed. 49:8950-8953.
8. Heep M, et al. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:107-110. (Pubitemid 32059577)
9. Huang HR, et al. 2001. Characterization of rpoB mutation in rifampin-resistant clinical Mycobacterium tuberculosis isolates from China. Chin. J. Tuberc. Respir. Dis. 24:231-235.
10. International Union against Tuberculosis and Lung Disease. 2000. Anti-tuberculosis drug resistance in the world. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Prevalence and Trends, WHO/I-UATLD. Report 21-107. World Health Organization, Geneva, Switzerland.
11. Kapur V, et al. 1994. Characterization by automated DNA sequencing of mutations in the gene rpoB encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:10952-10981.
12. Kolpashchikov DM. 2008. Split DNA enzyme for visual single nucleotide polymorphism typing. J. Am. Chem. Soc. 130:2934-2935. (Pubitemid 351455954)
13. Lee AS, Lim IH, Tang LL, Wong SY. 2005. High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J. Clin. Microbiol. 43:2026-2027.
14. Li D, Shlyahovsky B, Elbaz J, Willner I. 2007. Amplified analysis of low-molecular-weight substrates or proteins by the self-assembly of DNAzyme-aptamer conjugates. J. Am. Chem. Soc. 129:5804-5805. (Pubitemid 46748470)
15. Matsiota-Bernard P, Vrioni G, Marinis E. 1998. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 36:202-231.
16. Morris S, et al. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
17. Neo JL, Aw KD, Uttamchandani M. 2011. Visual SNP genotyping using asymmetric PCR and split DNA enzymes. Analyst 136:1569-1572.
18. Ozkutuk N, Gazi H, Surucuoglu S, Ganduz A, Ozbakkaloglu B. 2007. Characterization of rpoB mutations by line probe assay in rifampin-resistant Mycobacterium tuberculosis clinical isolates from the Aegean region in Turkey. Jpn. J. Infect. Dis. 60:211-213. (Pubitemid 47365044)
19. Piatek A, et al. 1998. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat. Biotechnol. 16:359-363.
20. Pozzi G, et al. 1999. RpoB mutation in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J. Clin. Microbiol. 37:11972-11991.
21. Sajduda A, et al. 2004. Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol. 42:2425-2431. (Pubitemid 38747484)
22. Sougakoff W, et al. 2004. Use of a high-density DNA probe array for detecting mutations involved in rifampin resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 10:289-294. (Pubitemid 38519354)
23. Telenti A, et al. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
24. Torres MJ, Criado A, Palomares JC, Aznar J. 2000. Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3194-3199.
25. Travascio P, Bennet AJ, Wang DY, Sen D. 1999. A ribozyme and a catalytic DNA with peroxidase activity, active sites versus cofactor-binding sites. Chem. Biol. 6:779-787.
26. Travascio P, Li Y, Sen D. 1998. DNA-enhanced peroxidase activity of a DNA-aptamer-hemin complex. Chem. Biol. 5:505-517. (Pubitemid 28436727)
27. Travascio P, Witting PK, Mauk AG, Sen D. 2001. The peroxidase activity of a hemin-DNA oligonucleotide complex, free radical damage to specific guanine bases of the DNA. J. Am. Chem. Soc. 123:1337-1348. (Pubitemid 32167324)
28. Troesch A, Nguyen H, Miyada CG. 1999. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J. Clin. Microbiol. 37:49-55. (Pubitemid 29004179)
29. Varma-Basil M, et al. 2004. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J. Clin. Microbiol. 42:5512-5516. (Pubitemid 39664329)
30. Williams DL, et al. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:23802-23861.
31. World Health Organization. 2011. WHO fact sheet, no. 310. World Health Organization, Geneva, Switzerland.
32. Xiao Y, et al. 2004. Catalytic beacons for the detection of DNA and telomerase activity. J. Am. Chem. Soc. 126:7430-7431. (Pubitemid 38781463)